Normal hepatic function
Showing 1 - 25 of >10,000
Hepatic Impairment, Healthy Trial in Saint Paul, San Antonio (Obicetrapib)
Not yet recruiting
- Hepatic Impairment
- Healthy
-
Saint Paul, Minnesota
- +1 more
Sep 21, 2023
Hepatic Impairment Trial (Elacestrant diHCl)
Not yet recruiting
- Hepatic Impairment
- Elacestrant dihydrochloride
- (no location specified)
Nov 6, 2023
Non-alcoholic Steatohepatitis, Hepatic Impairment, Cirrhosis Trial in Orlando, San Antonio, Kistarcsa (TVB-2640 - 50 mg)
Not yet recruiting
- Non-alcoholic Steatohepatitis
- +2 more
- TVB-2640 - 50 mg
-
Orlando, Florida
- +2 more
Apr 17, 2023
Subjects With Liver Function Injury, Normal Liver Function Subject Trial in Changchun (Deuremidevir Hydrobromide Tablets)
Completed
- Subjects With Liver Function Injury
- Normal Liver Function Subject
- Deuremidevir Hydrobromide Tablets
-
Changchun, Jilin, ChinaThe First Hospital of Jilin University Ethics Committee
Oct 16, 2023
Pharmacokinetics, Hepatic Impairment Trial in Knoxville (MDMA)
Not yet recruiting
- Pharmacokinetics
- Hepatic Impairment
-
Knoxville, TennesseeAlliance for Multispecialty Research, LLC.
Aug 17, 2022
Hepatic Function Abnormal Trial in Germany, United States (Venglustat (GZ402671))
Recruiting
- Hepatic Function Abnormal
- Venglustat (GZ402671)
-
Miami, Florida
- +3 more
Jan 30, 2023
Hepatic Impairment, Healthy Volunteers Trial in München, Gdansk, Bratislava (NNC0194-0499)
Not yet recruiting
- Hepatic Impairment
- Healthy Volunteers
-
München, Germany
- +2 more
Jun 27, 2023
Hepatic Function Abnormal Trial (Fexinidazole (HOE239))
Not yet recruiting
- Hepatic Function Abnormal
- Fexinidazole (HOE239)
- (no location specified)
Jan 10, 2023
Hepatic Impairment Trial in Szikszo (Part 1; LOU064 (Remibrutinib), Part 2; LOU064 (Remibrutinib))
Recruiting
- Hepatic Impairment
- Part 1; LOU064 (Remibrutinib)
- Part 2; LOU064 (Remibrutinib)
-
Szikszo, HungaryNovartis Investigative Site
Feb 22, 2023
Prevention of Thromboembolic Events, Atrial Fibrillation, Acute Myocardial Infarction Trial in Kiel (Asundexian (BAY2433334))
Recruiting
- Prevention of Thromboembolic Events
- +4 more
- Asundexian (BAY2433334)
-
Kiel, Schleswig-Holstein, GermanyCRS-Kiel
Jan 17, 2023
Hepatic Insufficiency, Healthy Subjects Trial in Suzhou (Jaktinib Hydrochloride Tablets)
Recruiting
- Hepatic Insufficiency
- Healthy Subjects
- Jaktinib Hydrochloride Tablets
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Nov 29, 2021